HS
GCVRZ

Horan Securities’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Horan Securities’s Portfolio GCVRZ Stock Details GCVRZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-30
Closed – – 254
2019
Q3 		$0 Hold
30
– – ﹤0.01% 307
2019
Q2 		$0 Hold
30
– – ﹤0.01% 303
2019
Q1 		$0 Hold
30
– – ﹤0.01% 247
2018
Q4 		$0 Hold
30
– – ﹤0.01% 240
2018
Q3 		$0 Hold
30
– – ﹤0.01% 232
2018
Q2 		$0 Hold
30
– – ﹤0.01% 239
2018
Q1 		$0 Hold
30
– – ﹤0.01% 220
2017
Q4 		$0 Hold
30
– – ﹤0.01% 216
2017
Q3 		$0 Hold
30
– – ﹤0.01% 200
2017
Q2 		$0 Hold
30
– – ﹤0.01% 191
2017
Q1 		$0 Buy
+30
New +$13 ﹤0.01% 185
2016
Q4 		– Sell
-30
Closed – – 160
2016
Q3 		$0 Buy
+30
New +$8 ﹤0.01% 161

Other funds holding GCVRZ

SCM
Stonehill Capital Management New York $197M AUM 96.45% 1-Year Est. Return
EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
BCM
Brigade Capital Management New York $806M AUM 20.71% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
WA
Whitebox Advisors Minneapolis, Minnesota $8.12B AUM 15.85% 1-Year Est. Return
NGA
New Generation Advisors Manchester, Massachusetts $45.6M AUM 15.43% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
MFP
Michael F. Price $846M AUM 0.07% 1-Year Est. Return

Horan Securities's GCVRZ Position: Q4 2019 in Review

Horan Securities sold out of Sanofi Contingent Value Rights (GCVRZ) in Q4 2019, closing a stake of 30 shares.

Horan Securities first reported a position in GCVRZ in Q3 2016 and held it in 12 quarters. The position peaked at $0 in Q3 2019. 103 funds tracked by Wall St. Rank hold GCVRZ as of Q4 2019.

  • Horan Securities reported no remaining Sanofi Contingent Value Rights position as of Q4 2019 after selling out during the quarter.
  • Horan Securities sold 30 Sanofi Contingent Value Rights shares in Q4 2019.
  • Horan Securities first reported a position in Sanofi Contingent Value Rights in Q3 2016 and held it in 12 quarters.
  • Horan Securities's Sanofi Contingent Value Rights position peaked at $0 in Q3 2019.
  • 103 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q4 2019.

Based on Horan Securities's 13F filing for Q4 2019, filed 5 Feb 2020.